Works matching IS 20590105 AND DT 2021 AND VI 6 AND IP 1


Results: 162
    1

    The future of Japanese encephalitis vaccination: expert recommendations for achieving and maintaining optimal JE control.

    Published in:
    NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00338-z
    By:
    • Vannice, Kirsten S.;
    • Hills, Susan L.;
    • Schwartz, Lauren M.;
    • Barrett, Alan D.;
    • Heffelfinger, James;
    • Hombach, Joachim;
    • Letson, G. William;
    • Solomon, Tom;
    • Marfin, Anthony A.;
    • the Japanese encephalitis vaccination experts panel;
    • Anderson, Katie;
    • Fischer, Marc;
    • Fox, Kim;
    • Jacobson, Julie;
    • Liyanage, Jayantha;
    • Marks, Florian;
    • Ogbuanu, Ike;
    • Tharmaphornpilas, Piyanit
    Publication type:
    Article
    2
    3
    4
    5

    Enhanced dengue vaccine virus replication and neutralizing antibody responses in immune primed rhesus macaques.

    Published in:
    NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00339-y
    By:
    • McCracken, Michael K.;
    • Kuklis, Caitlin H.;
    • Kannadka, Chandrika B.;
    • Barvir, David A.;
    • Sanborn, Mark A.;
    • Waickman, Adam T.;
    • Siegfried, Hayden C.;
    • Victor, Kaitlin A.;
    • Hatch, Kristin L.;
    • De La Barrera, Rafael;
    • Walls, Shannon D.;
    • Rutvisuttinunt, Wiriya;
    • Currier, Jeffrey R.;
    • Friberg, Heather;
    • Jarman, Richard G.;
    • Gromowski, Gregory D.
    Publication type:
    Article
    6

    Antibody avidity, persistence, and response to antigen recall: comparison of vaccine adjuvants.

    Published in:
    NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00337-0
    By:
    • Budroni, Sonia;
    • Buricchi, Francesca;
    • Cavallone, Andrea;
    • Bourguignon, Patricia;
    • Caubet, Magalie;
    • Dewar, Vincent;
    • D'Oro, Ugo;
    • Finco, Oretta;
    • Garçon, Nathalie;
    • El Idrissi, Mohamed;
    • Janssens, Michel;
    • Leroux-Roels, Geert;
    • Marchant, Arnaud;
    • Schwarz, Tino;
    • Van Damme, Pierre;
    • Volpini, Gianfranco;
    • van der Most, Robbert;
    • Didierlaurent, Arnaud M.;
    • Burny, Wivine
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Meta-analysis of HIV-1 vaccine elicited mucosal antibodies in humans.

    Published in:
    NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00305-8
    By:
    • Seaton, Kelly E.;
    • Deal, Aaron;
    • Han, Xue;
    • Li, Shuying S.;
    • Clayton, Ashley;
    • Heptinstall, Jack;
    • Duerr, Ann;
    • Allen, Mary A.;
    • Shen, Xiaoying;
    • Sawant, Sheetal;
    • Yates, Nicole L.;
    • Spearman, Paul;
    • Churchyard, Gavin;
    • Goepfert, Paul A.;
    • Maenza, Janine;
    • Gray, Glenda;
    • Pantaleo, Giuseppe;
    • Polakowski, Laura;
    • Robinson, Harriet L.;
    • Grant, Shannon
    Publication type:
    Article
    16
    17
    18

    ChAdOx1 nCoV-19 (AZD1222) vaccine candidate significantly reduces SARS-CoV-2 shedding in ferrets.

    Published in:
    NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00315-6
    By:
    • Marsh, Glenn A.;
    • McAuley, Alexander J.;
    • Au, Gough G.;
    • Riddell, Sarah;
    • Layton, Daniel;
    • Singanallur, Nagendrakumar B.;
    • Layton, Rachel;
    • Payne, Jean;
    • Durr, Peter A.;
    • Bender, Hannah;
    • Barr, Jennifer A.;
    • Bingham, John;
    • Boyd, Victoria;
    • Brown, Sheree;
    • Bruce, Matthew P.;
    • Burkett, Kathie;
    • Eastwood, Teresa;
    • Edwards, Sarah;
    • Gough, Tamara;
    • Halpin, Kim
    Publication type:
    Article
    19
    20

    Immunogenicity and efficacy of mRNA COVID-19 vaccine MRT5500 in preclinical animal models.

    Published in:
    NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00324-5
    By:
    • Kalnin, Kirill V.;
    • Plitnik, Timothy;
    • Kishko, Michael;
    • Zhang, Jinrong;
    • Zhang, Donghui;
    • Beauvais, Adrien;
    • Anosova, Natalie G.;
    • Tibbitts, Tim;
    • DiNapoli, Josh;
    • Ulinski, Gregory;
    • Piepenhagen, Peter;
    • Cummings, Sheila M.;
    • Bangari, Dinesh S.;
    • Ryan, Susan;
    • Huang, Po-Wei D.;
    • Huleatt, James;
    • Vincent, Deanne;
    • Fries, Katherine;
    • Karve, Shrirang;
    • Goldman, Rebecca
    Publication type:
    Article
    21
    22

    Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer.

    Published in:
    NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00297-5
    By:
    • Tanyi, Janos L.;
    • Chiang, Cheryl L.-L.;
    • Chiffelle, Johanna;
    • Thierry, Anne-Christine;
    • Baumgartener, Petra;
    • Huber, Florian;
    • Goepfert, Christine;
    • Tarussio, David;
    • Tissot, Stephanie;
    • Torigian, Drew A.;
    • Nisenbaum, Harvey L.;
    • Stevenson, Brian J.;
    • Guiren, Hajer Fritah;
    • Ahmed, Ritaparna;
    • Huguenin-Bergenat, Anne-Laure;
    • Zsiros, Emese;
    • Bassani-Sternberg, Michal;
    • Mick, Rosemarie;
    • Powell, Daniel J.;
    • Coukos, George
    Publication type:
    Article
    23

    Author Correction: Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer.

    Published in:
    2021
    By:
    • Tanyi, Janos L.;
    • Chiang, Cheryl L.-L.;
    • Chiffelle, Johanna;
    • Thierry, Anne-Christine;
    • Baumgartener, Petra;
    • Huber, Florian;
    • Goepfert, Christine;
    • Tarussio, David;
    • Tissot, Stephanie;
    • Torigian, Drew A.;
    • Nisenbaum, Harvey L.;
    • Stevenson, Brian J.;
    • Guiren, Hajer Fritah;
    • Ahmed, Ritaparna;
    • Huguenin-Bergenat, Anne-Laure;
    • Zsiros, Emese;
    • Bassani-Sternberg, Michal;
    • Mick, Rosemarie;
    • Powell, Daniel J.;
    • Coukos, George
    Publication type:
    Correction Notice
    24
    25
    26
    27
    28
    29
    30
    31
    32

    Neutrophil subtypes shape HIV-specific CD8 T-cell responses after vaccinia virus infection.

    Published in:
    NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00314-7
    By:
    • Di Pilato, Mauro;
    • Palomino-Segura, Miguel;
    • Mejías-Pérez, Ernesto;
    • Gómez, Carmen E.;
    • Rubio-Ponce, Andrea;
    • D'Antuono, Rocco;
    • Pizzagalli, Diego Ulisse;
    • Pérez, Patricia;
    • Kfuri-Rubens, Raphael;
    • Benguría, Alberto;
    • Dopazo, Ana;
    • Ballesteros, Iván;
    • Sorzano, Carlos Oscar S.;
    • Hidalgo, Andrés;
    • Esteban, Mariano;
    • Gonzalez, Santiago F.
    Publication type:
    Article
    33
    34

    Lipid nanoparticle encapsulated nucleoside-modified mRNA vaccines elicit polyfunctional HIV-1 antibodies comparable to proteins in nonhuman primates.

    Published in:
    NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00307-6
    By:
    • Saunders, Kevin O.;
    • Pardi, Norbert;
    • Parks, Robert;
    • Santra, Sampa;
    • Mu, Zekun;
    • Sutherland, Laura;
    • Scearce, Richard;
    • Barr, Maggie;
    • Eaton, Amanda;
    • Hernandez, Giovanna;
    • Goodman, Derrick;
    • Hogan, Michael J.;
    • Tombacz, Istvan;
    • Gordon, David N.;
    • Rountree, R. Wes;
    • Wang, Yunfei;
    • Lewis, Mark G.;
    • Pierson, Theodore C.;
    • Barbosa, Chris;
    • Tam, Ying
    Publication type:
    Article
    35
    36

    Immunofocusing humoral immunity potentiates the functional efficacy of the AnAPN1 malaria transmission-blocking vaccine antigen.

    Published in:
    NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00309-4
    By:
    • Bender, Nicole G.;
    • Khare, Prachi;
    • Martinez, Juan;
    • Tweedell, Rebecca E.;
    • Nyasembe, Vincent O.;
    • López-Gutiérrez, Borja;
    • Tripathi, Abhai;
    • Miller, Dustin;
    • Hamerly, Timothy;
    • Vela, Eric M.;
    • Davis, Ryan R.;
    • Howard, Randall F.;
    • Nsango, Sandrine;
    • Cobb, Ronald R.;
    • Harbers, Matthias;
    • Dinglasan, Rhoel R.
    Publication type:
    Article
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47

    Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory disease.

    Published in:
    NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00301-y
    By:
    • van der Lubbe, Joan E. M.;
    • Rosendahl Huber, Sietske K.;
    • Vijayan, Aneesh;
    • Dekking, Liesbeth;
    • van Huizen, Ella;
    • Vreugdenhil, Jessica;
    • Choi, Ying;
    • Baert, Miranda R. M.;
    • Feddes-de Boer, Karin;
    • Izquierdo Gil, Ana;
    • van Heerden, Marjolein;
    • Dalebout, Tim J.;
    • Myeni, Sebenzile K.;
    • Kikkert, Marjolein;
    • Snijder, Eric J.;
    • de Waal, Leon;
    • Stittelaar, Koert J.;
    • Tolboom, Jeroen T. B. M.;
    • Serroyen, Jan;
    • Muchene, Leacky
    Publication type:
    Article
    48
    49

    ChAdOx1-vectored Lassa fever vaccine elicits a robust cellular and humoral immune response and protects guinea pigs against lethal Lassa virus challenge.

    Published in:
    NPJ Vaccines, 2021, v. 6, n. 1, p. 1, doi. 10.1038/s41541-021-00291-x
    By:
    • Fischer, Robert J.;
    • Purushotham, Jyothi N.;
    • van Doremalen, Neeltje;
    • Sebastian, Sarah;
    • Meade-White, Kimberly;
    • Cordova, Kathleen;
    • Letko, Michael;
    • Jeremiah Matson, M.;
    • Feldmann, Friederike;
    • Haddock, Elaine;
    • LaCasse, Rachel;
    • Saturday, Greg;
    • Lambe, Teresa;
    • Gilbert, Sarah C.;
    • Munster, Vincent J.
    Publication type:
    Article
    50